Petra Pharma Overview

  • Founded
  • 2015
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Petra Pharma General Information

Description

Developer of a phosphoinositide (PI) signaling pathways intended to treat cancer and metabolic diseases. The company develops small molecules to target cellular processes to therapeutically impact human health including cell division, growth, trafficking and signaling, enabling doctors to access novel drugs that may help them treat their patients

Contact Information

Website
www.petrapharmacorp.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 450 East 29th Street
  • Suite 506
  • New York, NY 10016
  • United States
+1 (646) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Petra Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 14-May-2020 000.00 Completed Generating Revenue
2. Early Stage VC 31-Mar-2020 000.00 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 06-Jan-2016 $48M $48M 0000 Completed Startup
To view Petra Pharma’s complete valuation and funding history, request access »

Petra Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view Petra Pharma’s complete cap table history, request access »

Petra Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a phosphoinositide (PI) signaling pathways intended to treat cancer and metabolic diseases. The company dev
Drug Discovery
New York, NY
000.00
000000&0 000.00

00000 00

didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000 000000000
Cambridge, MA
00 As of 0000
0000
000 0000-00-00
00000000000 0000

00000000

cing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim venia
0000 000000000
San Diego, CA
000 As of 0000
00000
0000000 0000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Petra Pharma Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rheos Medicines Venture Capital-Backed Cambridge, MA 00 0000 00000000000 0000
000000000 00000000 Private Equity-Backed San Diego, CA 000 00000 0000000 0000 00000
00000 000000000000 Corporation Pasadena, CA 0 00.000 00000000 00.000
00000 000000000000 Venture Capital-Backed South San Francisco, CA 00 00000 000000000 00000
0000 00000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
You’re viewing 5 of 33 competitors. Get the full list »

Petra Pharma Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
180 Degree Capital Hedge Fund Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Accelerator Life Science Partners Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial